[Seizure-linked hippocampal plasticity and protection against excitotoxicity: possible role of neuropeptide-y]

Neurochirurgie. 1998 Mar;44(1):31-7.
[Article in French]

Abstract

Background and purpose: Changes occurring in neuropeptide-Y immunoreactivity after kainic acid injection in rats and their possible consequences on seizure-brain damage were studied.

Methods: First, an intra-hippocampal kainic acid injection was performed (n = 7), inducing an ectopic and bilateral neuropeptide-Y immunoreactivity in mossy fibers. On the side of the injection, this neuropeptide-Y staining was associated with dramatic neuronal loss whereas, in the contralateral hippocampus staining was observed without associated neuronal loss. The CA3 a-b pyramidal cell loss induced by an intra-ventricular kainic acid injection was then compared between a control group (n = 6) and a pre-conditioned group (n = 6) characterized by neuropeptide-Y staining in the mossy fibers obtained by a previous contralateral intra-hippocampal kainic acid injection as described.

Results: In the pre-conditioned group, the CA3 a-b pyramidal cell loss was significantly lower (m = 33.5%) than in the control group (m = 86.6%). The neuropeptide-Y inhibiting the pre-synaptic release of glutamate, glutamate-related epileptic-brain damage could be reduced when neuropeptide-Y is expressed by granulated cells.

In conclusion: Seizure-linked plasticity could induce a self-protection phenomenon against excitotoxic lesions possibly partially mediated by de novo neuropeptide-Y mossy fiber expression.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Cell Count / drug effects
  • Epilepsy / chemically induced*
  • Epilepsy / prevention & control*
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Immunohistochemistry
  • Kainic Acid*
  • Mossy Fibers, Hippocampal / drug effects
  • Mossy Fibers, Hippocampal / metabolism
  • Neuronal Plasticity / drug effects
  • Neuropeptide Y / metabolism*
  • Neuropeptide Y / physiology
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / metabolism
  • Rats
  • Rats, Wistar

Substances

  • Neuropeptide Y
  • Kainic Acid